Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sanofi India Ltd

+ Add to Watchlist

SANL:IN

3,311.75 INR 33.00 1.01%

As of 05:59:51 ET on 05/26/2015.

Snapshot for Sanofi India Ltd (SANL)

Open: 3,262.05 Day's Range: 3,259.80 - 3,318.15 Volume: 2,030
Previous Close: 3,278.75 52wk Range: 2,722.23 - 3,787.79 1-Yr Rtn: +13.87%

Stock Chart for SANL

No chart data available.
  • SANL:IN 3,302.65
  • 1D
  • 1M
  • 1Y
3,278.75
Interactive SANL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SANL

Current P/E Ratio (ttm) 52.5708
Estimated P/E(12/2015) -
Relative P/E vs. SENSEX 2.4698
Earnings Per Share (INR) (ttm) 62.9960
Est. EPS (INR) (12/2015) -
Est. PEG Ratio -
Market Cap (M INR) 76,269.60
Shares Outstanding (M) 23.03
30 Day Average Volume 23,081
Price/Book (mrq) 14.5617
Price/Sale (ttm) 9.4415
Dividend Indicated Gross Yield 1.03%
Cash Dividend (INR) 24.0000
Dividend Ex-Date 04/16/2015
5 Year Dividend Growth 17.61%
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SANL

No data available

Company Profile & Key Executives for SANL

Sanofi India Limited manufactures pharmaceuticals and chemicals. The Company has a worldwide presence, an extensive portfolio of prescription medicines, a portfolio of vaccines, major biological products, generics medicines, consumer healthcare, animal healthcare, and has a presence in both traditional and emerging markets.

Shailesh AyyangarManaging DirectorVirginie Simone Jeanine Verrechia "Virginie Boucinha"Chief Financial Officer
Chowdhury AnindyaSenior Dir:Consumer HealthcareWadhawan LalitSenior Dir:Nutraceuticals BU
More Company Profile & Key Executives for SANL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil